What Are Digital Therapeutics (DTx)?
Digital therapeutics (DTx) are clinically validated, software-based interventions designed to prevent, manage, or treat disorders. Unlike generic wellness apps, DTx are often FDA-authorized, prescribed by a provider, and backed by clinical research. For addiction treatment, they represent a scalable and accessible complement to traditional therapy models. (BMJ General Psychiatry)
Spotlight: RESET® & RESET‑O®
Two of the most notable DTx tools for addiction are RESET® and RESET-O®, originally developed by Pear Therapeutics and now relaunched by PursueCare.
- RESET® is designed for general substance use disorders.
- RESET-O® is tailored for opioid use disorder and integrates with medication-assisted treatment (MAT), including buprenorphine.
Both programs offer 12-week cognitive behavioral therapy modules, interactive lessons, and contingency management, where patients earn rewards for progress and adherence.
These apps are FDA-authorized and covered by many insurers, including Medicare and Medicaid, making them a breakthrough for access and affordability.
What the Research Shows
A randomized controlled trial in Korea published in Frontiers in Psychiatry showed that app-based CBT led to a 73% abstinence rate at 12 weeks, compared to 31% in traditional therapy. (Frontiers in Psychiatry, 2024)
In the U.S., multiple studies found that RESET-O® improved treatment retention and reduced relapse risk when used alongside MAT.
These tools are also being used in emerging programs like WEconnect, which reduced opioid use by 35% and improved retention by 19% in a recent pilot program at UT Health San Antonio.
Why DTx Are Game-Changers
- Accessible: DTx expands support to individuals in rural or underserved areas.
- Private: Ideal for those hesitant about group or in-person therapy.
- Engaging: Apps use reminders, quizzes, and gamification to maintain patient involvement.
- Scalable: One program can serve thousands without compromising quality.
Experts also believe that DTx may reduce stigma by offering a discreet, tech-forward path to recovery. (STAT News)
Challenges to Consider
While promising, digital therapeutics aren’t a silver bullet:
- Engagement: Like many apps, users may drop off without human encouragement.
- Access: Some patients lack smartphones or digital literacy.
- Integration: DTx works best when paired with a clinician-led treatment plan—not as a stand-alone solution. (Psychiatric Times)
What This Means for the Future — and for Hygea
At Hygea, we are committed to combining evidence-based care with emerging tools that support long-term recovery. While digital therapeutics may not be the right fit for every patient, they represent a powerful opportunity to extend support after residential care ends.
We’re actively exploring technology partnerships and tools that will help us deliver more personalized, scalable, and effective care—always grounded in the human connection that makes recovery possible.
Final Thoughts
Digital therapeutics are reshaping the way addiction is treated—from smartphones to structured recovery. These tools are not meant to replace care but enhance it, offering real-time support, clinically proven strategies, and expanded access for those who need it most.
If you’re beginning your recovery journey or supporting someone who is, Hygea is an addiction treatment center in Maryland that offers forward-thinking, compassionate treatment—every step of the way.